Abstract
The term antiandrogen had already appeared several times over the years up to 1963. Estrogens, for instance, were thought to have antiandrogenic properties because they could inhibit the growth of the comb in chicks and roosters — a classical parameter of androgenic action (Gley and Delor 1937 a, b; Muhlenbock 1938 a, b, c, d). Mammals, however, do not display any direct antagonism between androgens and estrogens (Neumann et al. 1968). Other substances, socalled partial agonists/antagonists, displayed antiandrogenic properties only within a certain dose range — at high doses they were androgenic. This phenomenon, i.e., that a weak hormone at an appropriate dosage can to some extent suppress the action of a strong hormone, can be explained by the mechanism of action of sex hormones working via steroid receptor binding. Naturally, such weak androgens with only limited antiandrogenic properties had not found any particular interest. These substances were in any case unsuitable for clinical application.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adachi K, Takayasu S (1972) The mechanisms of testosterone action of the sebaceous glands of the Syrian hamster. In: Montagna W, Van Scott EJ, Stoughton RB (eds) Pharmacology and the skin. Appleton-Century-Crofts, New York, pp 381–401 (Advances in biology of skin, vol 12)
Albring M, Schumann P, Okon C, Schleusener A (1982) SH-434 — a topically active inhibitor of sebum production. Arch Dermatol Res 273:170–171
Anderson KM, Liao S (1968) Selective retention of dihydrotestosterone by prostatic nuclei. Nature 219:277–279
Archibald A, Shuster S (1967) Bioassay of androgen using the rat sebaceous gland. J Endocrinol 37:XXII
Archibald A, Shuster S (1970) The measurement of sebum secretion in the rat. Br J Dermatol 82:146–151
Beach F, Westbrook W (1968) Morphological and behavioral effects of an antiandrogen in male rats. J Endocrinol 42:379–382
Belham JE, Neal GE, Williams DC (1969) Testosterone metabolism in the rat ventral prostate. Biochim Biophys Acta 187:159–162
Beyer J, Demisch K, Wiegelmann W, Happ J, Kollmann F, Schoffling K (1973) Cyproterone acetate in the treatment of infantile androgenital syndrome with precocious puberty. Acta Endocrinol [Suppl] (Copenh) 173:169
Bierich JR (1970) Pubertas praecox and pubertas tarda (precocious and retarded puberty). Symp Dtsch Ges Endokrinol 16:183–194
Binder S, Roters G, Schultka H (1971) Klinische und experimentell-psychologische Untersuchungen zur Wirkung des Antiandrogens Cyproteronacetat bei erheblich vermindert zurechnungsfähigen und zurechnungsunfahigen Sexualdelinquenten. Nervenarzt 42:26–32
Bloch GJ, Davidson JM (1967) Antiandrogen implanted in brain stimulates male reproductive system. Science 155:593–595
Bloch GJ, Davidson JM (1971) Behavioral and somatic responses to the antiandrogen cyproterone (l,2a-methylene-6-chloro-∆6-17a-hydroxyprogesterone). Horm Behav 2:11
Boissello A, Tremblay RR (1978) Clinical usefullness of spironolactone in the treatment of acne and hirsutism. Clin Res 26:840A
Bossi E, Zurbrügg RP (1973) Behandlung der Pubertas praecox mit dem Antiandrogen Cyproteronacetat. Klin Wochenschr 51:774
Bossi E, Joss EE, Zurbrügg RP (1973 a) Evaluation of the effectiveness of treatment on adult height prognosis in disorders with advanced and retarded bone age. Acta Paediatr Scand 62:401–404
Bossi E, Zurbrügg RP, Joss EE (1973 b) Improvement of adult height prognosis in precocious puberty by cyproterone acetate. Acta Paediatr Scand 62:405–412
Bossi E, Zurbrügg RP, Joss EE (1973 c) Cyproteronacetat und Pubertas praecox. Med Mitt Schering AG 2:19–25
Bracci U, Di Silverio F (1972) Il nostro attuale orientamento in tema di terapia ormonale del cancro della prostata. Preview of the Congress die Chirurgia Internazionale, Rome
Brinkmann AO, Lindh LM, Breedveld DI, Mulder E, van der Molen HJ (1983) Cyproterone acetate prevents translocation of the androgen receptor in the rat prostate. Mol Cell Endocrinol 32:117–129
Bruchovsky N, Wilson JD (1968 a) The conversion of testosterone to 5a-androstan-17/ß-ol-3-one by rat prostate in vivo and in vitro. J Biol Chem 243:2012–2021
Bruchovsky N, Wilson JD (1968 b) The intranuclear binding of testosterone and 5a-androstan-17/ß-ol-3-one by rat prostate. J Biol Chem 243:5953–5960
Bullough WS (1946) Mitotic activity in the adult female mouse, mus L., a study of its relation to the oestrous cycle in normal and abnormal conditions. Philos Trans R Soc Lond [Biol] 231:435–517
Burdick KH, Hill R (1970) The topical effect of the antiandrogen Chlormadinone acetate and some of its chemical modifications on the hamster costovertebral organ. Br J Dermatol 82 [Suppl 6]: 19–25
Burton JL, Libman LJ, Cunliffe WJ, Wilkinson R, Hall R, Shuster S (1972) Sebum excretion in acromegaly. Br Med J 1:406–408
Callantine MR, Clemens LE, Shih YH (1968) Displacement of 17/ß-estradiol from uterine receptor sites by an estrogen antagonist. Proc Soc Exp Biol Med 128:382–386
Chalbos D, Rochefort H (1984) Dual effects of the progestin R 5020 on proteins related by the T 47 D human breast cancer cell. J Biol Chem 259:1231–1238
Cook TJ, Lorincz AL (1963) Enzymatic determination of hydroxy-steroids in human skin surface lipids. J Invest Dermatol 41:265–268
Cooper MF, Thody AJ, Shuster S (1974) Hormonal regulation of cutaneous lipogenesis; effects of hypophysectomy, posteriorhypophysectomy and a-melanocyte-stimulating hormone treatment. Biochim Biophys Acta 360:193–204
Cunliffe WJ, Shuster S (1969) Pathogenesis of acne. Lancet I(7597):685–687
Darley CR, Moore JW, Besser GM, Munro DD, Kirby JD (1983) Low dose prednisolone or oestrogen in the treatment of women with late onset or persistent acne vulgaris. Br J Dermatol 108:345–353
Di Silverio F, Gagliardi V (1968/1969) Il cancero della prostata. Nostri orientamenti therapeutici nelle forme estrogeno-resistenti. Estratto da: bolletino ed atti della Società die Urologia Centro-Meridionale e delle Isole, voi 5
Dorfman RI (1970) Biological activity of antiandrogens. Br J Dermatol 82 [Suppl 6]:3–8
Downes AM, Wallace ALC (1965) Local effects on wool growth of intradermal injections of hormones. In: Lyne AG, Short BF (eds) Biology of the skin and hair growth. Angus and Robertson, Sydney, pp 679–703
Ebling FJ (1951) Sebaceous glands. 2. Changes in sebaceous glands following implantation of oestradiol benzoae in female albino rat. J Endocrinol 7:288–298
Ebling F J (1967) The action of an antiandrogenic steroid, 17a-methyl-B-nortestosterone, on sebum secretion in rats treated with testosterone. J Endocrinol 38:181–185
Ebling FJ, Skinner J (1967) The measurement of sebum production in rats treated with testosterone and oestradiol. Br J Dermatol 79:386–393
Ebling F J, Randall VA, Skinner J (1981) Local suppression of sebum secretion in rats by topical cyproterone acetate in ethanol. J Invest Dermatol 77:458–463
Fang S, Anderson KM, Liao S (1969) Receptor proteins for androgens. On the role of specific proteins in selective retention of 17ßHydroxy-5-androstan-3-one by the rat ventral prostate in vivo and in vitro. J Biol Chem 244:6584–6595
Fang S, Liao S (1969) Antagonistic action of antiandrogens on the formation of a specific dihydrotestosterone-receptor protein complex in rat ventral prostate. Mol Pharmacol 5:428–431
Ferrari RA, Chakrabarty K, Creange JE, Beyler AL, Potts GO, Schane HP (1980) Endocrine profile of topterone, a topical antiandrogen, in three species of laboratory animals. Methods Find Exp Clin Pharmacol 2:65–69
Ferguson KA, Schinkel PG, Carter HB, Clarke WH (1956) The influence of the thyroid on wool follicle development in the lamb. Aust J Biol Sci 9:575–585
Frost P, Gomez EC (1972) Inhibitors of sex hormones: development of experimental models. In: Montagna W, Van Scott EJ, Stoughton RB (eds) Pharmacology and the skin. Appleton- Century-Crofts, New York, pp 403–420 (Advances in biology of skin, vol XII)
Geller J, Fishman J (1971) Effect of cyproterone acetate on pituitary and gonadal function in elderly males. Clin Res 19:171
Geller J, Fruchtman B, Meyer C, Newman H (1967) Effect of progestational agents on gonadal and adrenal cortical function in patients with benign prostatic hypertrophy and carcinoma of the prostate. J Clin Endocrinol Metab 27:556–560
Geller J, Vazakas G, Fruchtman B, Newman H, Nakao K, Loh A (1968) The effect of cyproterone acetate on advanced carcinoma of the prostate. Surg Gynecol Obstet 127:748–758
Geynet C, Millet C, Truong H, Baulieu EE (1972) Estrogens and antiestrogens. Horm Antagonists Gynecol Invest 3:2–29
Giese H, Krause WJF, Schmidt H (1968) Sexualhormone in Beziehung zur Sexualität. Forum der Psychiatrie 20:189–200
Gley P, Delor J (1937 a) Sur le mécanisme de l’antagonisme entre la testostérone et la folliculine. CR Soc Biol 125:52–54
Gley P, Delor J (1937 b) Antagonisme entre la testostérone et la folliculine sur la crête du chapon. CR Soc Biol 125:813–815
Gomez EC, Frost P (1972) Testosterone metabolism and androgenic effect. In: Montagna W, Van Scott EJ, Stoughton RB (eds) Pharmacology and the skin. Appleton-Century-Crofts, New York, pp 367–379 (Advances in biology of skin, vol XII)
Goslar HG, Mehring M, Neumann F (1970) Einfluß der Antiandrogene Cyproteron und Cyproteronacetat auf das Enzymmuster im Hoden juveniler und erwachsener Ratten. Histochemie 23:51–58
Gräf K-J, Brotherton J, Neumann F (1974) Clinical uses of antiandrogens. In: Eichler O, Farah A, Herken AD, Welch H, (eds) Androgens II and antiandrogens. Springer, Berlin Heidelberg New York, pp 485–542 (Handbook of experimental pathology, vol 35/2)
Hall DWR, van den Hoven WE, Noordzij-Kamermans NJ, Jaitly KD (1983) Hormonal control of hamster ear sebaceous gland lipogenesis. Arch Dermatol Res 275:1–7
Hamada H, Neumann F, Junkmann K (1963) Intrauterine antimaskuline Beeinflussung von Rattenfeten durch stark gestagen wirksames Steroid. Acta Endocrinol (Copenh) 44:380–388
Hamilton JB (1941) Male hormone substance: a prime factor in acne. J Clin Endocrinol Metab 1:570–592
Hamilton JB, Mestler GE (1963) Low values for sebum in eunuchs and oophorectomized women. Proc Soc Exp Biol Med 112:374–378
Hamilton JB, Montagna W (1950) The sebaceous glands of the hamster. I. Morphological effects of androgens on integumentary structures. Am J Anat 86:191–234
Hasan SH, Neumann F, Schenk B (1973) Long-term effect of cyproterone on testosterone levels in male rats. Acta Endocrinol [Suppl] (Copenh) 173:119 (abstr)
Heap PF, Lederis K, Neumann F (1971) Effects of cyproterone on the ultrastructure of the rat adenohypophysis. In: Heller H, Lederis K (eds) Subcellular organization and function in endocrine tissues. University Press, Cambridge, pp 147–160
Helge H (1973) Frühreife. Monatsschr Kinderheilkd 121:636–646
Hertel P, Kramer M, Neumann F (1969) Einfluß eines Antiandrogens (Cyproteronacetat) auf Knochenwachstum und Knochenreifung männlicher Ratten. Arzneimittelforschung 19:1777–1790
Hoffet H (1968 a) Über die Anwendung des Testosteronblockers Cyproteronacetat (SH 714) bei Sexualdelinquenten und psychiatrischen Anstaltspatienten (vorläufige Mitteilung). Praxis 57:221–230
Hoffet H (1968 b) Die medizinischen Behandlungsmöglichkeiten von Sexualdelinquenten. Schweiz Z Strafrecht 84:378–394
Hoffet H (1969) Neue Wege in der Behandlung von Sexualdelinquenten. Kriminalistik 23:405
Horn H-J (1971) Der Leidensdruck als Indikationskriterium. Bemerkungen zur „medikamentösen Kastration“. Nervenarzt 42:312–316
Horn H-J (1972 a) Die Behandlung von Sexualdelinquenten mit Cyproteronacetat. In: Raspé G (ed) Schering Symposium über Sexualdeviationen und ihre medikamentöse Behandlung, Berlin 1971. Pergamon Press, New York, pp 113–123 (Life sciences monographs, vol 2)
Horn H-J (1972 b) Somatische Behandlungsmethoden im Strafvollzug. Kriminol Gegenwartsfragen 10:144–155
Horn H-J (1974) Administration of antiandrogens in hypersexuality and sexual deviations. In: Eichler O, Farah A, Herken AD, Welch H, (eds) Androgens II and antiandrogens. Springer, Berlin Heidelberg New York, pp 543–562 (Handbook of experimental pharmacology, vol 35/2)
Jensen EV, Jacobson HI (1962) Basic guides to the mechanism of estrogen action. Recent Prog Horm Res 18:387–414
Jensen EV, de Sombre ER, Hurst DJ, Kawashima T, Jungblut PW (1967 a) IV. Mode d’action des hormones intervenant dans la reproduction. Arch Anat Microsc Morphol Exp 56:547–569
Jensen EV, de Sombre ER, Jungblut PW (1967 b) In: Wissler RW, Dao JL, Wood S, (eds) Endogenous factors influencing host-tumor balance. University of Chicago Press, Chicago, p 15
Jensen EV, Suzuki T, Kawashima T, Stumpf WE, Jungblut PW, de Sombre ER (1968) A twostep mechanism for the interaction of estradiol with rat uterus. Proc Natl Acad Sci USA 59:632–638
Jensen EV, Mohla S, Brecher PI, de Sombre ER (1973) Estrogen receptor transformation and nuclear RNA synthesis. In: O’Malley BW, Means AR (eds) Receptors for reproductive hormones. Plenum, New York, pp 60–79
Junkmann K, Neumann F (1964) Zum Wirkungsmechanismus von an Feten antimaskulin wirksamen Gestagenen. Acta Endocrinol [Suppl] (Copenh) 90:139–154
Kahwanago I, Heinrichs WL, Herrmann WL (1970) Estradiol „receptors“in hypothalamus and anterior pituitary gland: inhibition of estradiol binding by SH-group blocking agents and clomiphene citrate. Endocrinology 86:1319–1320
Kaszynski E (1983) The stimulation of hair growth in the flank organs of female hamsters by subcutaneous testosterone propionate and its inhibition by topical cyproterone acetate: dose-response studies. Br J Dermatol 109:565–569
Knorr D (1970) Testosteron und Pubertät bei Knaben (Testosterone and puberty in males). In: 16. Symp Dtsch Gesellschaft für Endokrinologie. Springer, Berlin Heidelberg New York, pp 151–165
Korfsmeier KG, Davidoff M (1970) Autoradiographische Untersuchungen zur Mitoseaktivität im Hypophysenvorderlappen männlicher Ratten nach Behandlung mit Antiandrogenen und nach Kastration. Z Zellforsch 104:275–281
Krause WFJ (1969) Zur sogenannten hormonalen Kastration. Mater Med Nordmark 21:29–35
Krause WFJ (1972) Die chirurgische Kastration und ihre rechtlichen Grundlagen. In: Raspé G (ed) Schering Symposium über Sexualdeviationen und ihre medikamentöse Behandlung, Berlin 1971. Pergamon, Oxford, pp 133–145 (Life sciences monographs, vol 2)
Kröpfli P (1976) Untersuchungen zur Wirkung der Vitamin-A-Säure bei experimentell ausgelöster Follikelkeratose. Dermatológica 153:88–95
Krueger GG, Shelby J (1981) Biology of human skin transplanted to the nude mouse: I. Response to agents which modify expidermal proliferation. J Invest Dermatol 76:506–510
Laschet U (1971) Ergebnisse neuer medikamentöser Behandlungsmethoden bei Sexualdelinquenten. Kriminol Gegenwartsfragen 9:174–179
Laschet U, Laschet L (1968) Die Behandlung der pathologisch gesteigerten und abartigen Sexualität des Mannes mit dem Antiandrogen Cyproteronacetat. In: Klein E (ed) Das Testosteron — Die Struma. Springer, Berlin Heidelberg New York, pp 116–119
Laschet U, Laschet L (1971) Psychopharmacotherapy of sex offenders with cyproterone acetate. Pharmakopsychiat Neuro-Psychopharmakol 4:99–104
Läuppi E, Studer A (1959) Hemmung der experimentellen, testosteronbedingten Epidermisproliferation an der weiblichen Ratte durch ein synthetisches Phenanthrenderivat mit antiandrogener Wirkung. Experientia 15:264–265
Lawrence CH, Werthessen NT (1940) Endocrine dyscracia of acne vulgaris in women. Endocrinology 27:755–758
Lecaque D, Secchi J (1982) Ultrastructural changes of sebaceous glands in castrated and testosterone-treated male rats. Cell Tissue Res 226:621–628
Liao S, Fang S (1970) In: Griffiths K, Pierrepoint CG (eds) Some aspects of aetiology and biochemistry of prostate cancer. Alpha Omega Alpha, Cardiff
Luderschmidt C, Plewig G (1977) Effects of cyproterone acetate and carboxilic acid derivatives on the sebaceous glands of the Syrian hamster. Arch Dermatol Res 258:185–191
Luderschmidt C, Jawny J, Eiermann W (1983) Competitive inhibition of cyproterone acetate and 17a-propylmesterolone at the androgenic receptor. Arch Dermatol Res 275:276
Ludescher E, Rameis K, Gleispach H (1969) Antiandrogenbehandlung bei einem Knaben mit Pubertas praecox. Paediatr Paedol 5:316–325
Lyons F, Shuster S (1983) Indirect evidence that the action of cyproterone acetate on the skin is due to a metabolite. Clin Endocrinol 19:53–55
Mahesh VB, Zarate A, Roper BK, Greenblatt RB (1966) Studies on the action of 17a-methyl-B-nortestosterone as an antiandrogen. Steroids 8:297–308
Mainwaring WIP (1969) The binding of (1,2-3H) testosterone within nuclei of the rat prostate. J Endocrinol 44:323–333
Manning DD, Reed ND, Shaffer CF (1973) Maintenance of skin xenografts of widely divergent phylogenetic origin on congenitally athymic (nude) mice. J Exp Med 138:488
Matias JR, Orentreich N (1983 a) The hamster ear sebaceous glands. I. Examination of the regional variation by stripped skin planimetry. J Invest Dermatol 81:43–46
Matias JR, Orentreich N (1983 b) Stimulation of hamster sebaceous glands by epidermal growth factor. J Invest Dermatol 80:516–519
Mauermayer W (1971) Cyproterone therapy in prostatic cancer stage III and IV. In: Raspé G, Brosig W (eds) International Symposium on the Treatment of Carcinoma of the Prostate, Berlin, November 1969. Pergamon, Oxford, pp 179–180 (Life sciences monographs, vol 1)
Mauvais-Jarvis P, Kuttenn F, Mowszowicz I (1981) Hirsutism. Springer, Berlin Heidelberg New York (Monographs on endocrinology, vol 19)
Meilin P (1971) Cyproterone therapy in prostatic cancer stage IV. In: Raspé G, Brosig W (eds) International Symposium on the Treatment of Carcinoma of the Prostate, Berlin, November 1969. Pergamon, Oxford, p 180 (Life sciences monographs, vol 1)
Mietkiewski K, Lukaszyk A (1969) The response of the rat testis to prolonged administration of an androgen antagonist (cyproterone). Acta Endocrinol (Copenh) 60:561–570
Mietkiewski K, Malendowicz L, Lukaszyk A (1969) Cytological and cytochemical comparative study on the effect of cyproterone (antiandrogen) and gonadectomy on the gonadotrophic cells of the hypophysis in male rats. Acta Endocrinol (Copenh) 61:293–301
Morse HC, Leach DR, Rowley MJ, Heller CG (1973) Effect of cyproterone acetate on sperm concentration, seminal fluid volume, testicular cytology and levels of plasma and urinary ICSH, FSH and testosterone in normal men. J Reprod Fértil 32:365–378
Mothes C, Lehnert J, Samimi F, Ufer J (1972) Klinische Prüfung von Cyproteronacetat bei Sexualdeviationen — Gesamtauswertung. In: Raspé G (ed) Schering Symposium über Sexualdeviationen und ihre medikamentöse Behandlung, Berlin 1971. Pergamon, Oxford, pp 65–87 (Life science monographs, vol 2)
Mowszowicz I, Riahi M, Wright F, Bouchard P, Kuttenn F, Mauvais-Jarvis P (1981) Androgen receptor in human skin cytosol. J Clin Endocrinol Metab 52:338
Mühlenbock O (1938 a) Der Antagonismus der Wirkung der Kammwachstumsstoffe einerseits und der Östrogenen Stoffe und Progesteron andererseits. Acta Brevia Neer. Physiol Pharmacol Microbiol 8:50–52
Mühlenbock O (1938 b) Über die weitere Rückbildung des Kapaunenkammes nach östrogenem Hormon. Acta Brevia Neer Physiol Pharmacol Microbiol 8:142–146
Mühlenbock O (1938 c) Kongreß-Bericht XVI. Int Physiol Kongr Zürich
Mühlenbock O (1938d) Über den Antagonismus zwischen den Sexualhormonen. In: Kongreß-Bericht Int Kongr Gynäkol, Amsterdam, vol II. pp 491–495
Nehme-Haily D, Osario DG, Veeneman RJ, Markewitz M (1968) Resultados preliminares con el uso del acetato de ciproterona (SH-714) en el carcinoma prostatico avanzado. Ref Venez Urol 20:19–26
Neri RO (1971) Some biological properties of antiandrogens. In: James VHT, Martini L (eds) Hormonal steroids. Excerpta Medica, Amsterdam, pp 1022–1029
Neri RO (1976) Studies on the biology and mechanism of action of non-steroidal antiandrogens. Int symp on androgens and antiandrogens, April, Milan
Neri RO (1977) Studies on the biology and mechanism of action of nonsteroidal antiandrogen. In: Martini L, Motta M (eds) Androgens and antiandrogens. Raven, New York
Neri RO, Monahan M (1972) Effects of a novel nonsteroidal antiandrogen on canine prostatic hyperplasia. Invest Urol 10:123–130
Neri RO, Florance K, Koziol P, van Cleave S (1972) A biological profile of a nonsteroidal antiandrogen, Sch 13521 (4’-nitro-3’-trifluoromethylisobutyranilide). Endocrinology 91:427437
Neumann F (1966 a) Auftreten von Kastrationszellen im Hypophysenvorderlappen männlicher Ratten nach Behandlung mit einem Antiandrogen. Acta Endocrinol (Copenh) 53:53–60
Neumann F (1966b) Antagonismus von Testosteron und l,2a-Methylen-6-chlor-pregna-4,6-di-en-17a-ol-3,20-dion (Cyproteron) an den die Gonadotropinsekretion regulierenden Zentren bei männlichen Ratten. Acta Endocrinol (Copenh) 53:382–390
Neumann F (1976) Endokrinologische Aspekte der Geschlechtsdifferenzierung. Gynäkologe 9:16–29
Neumann F (1977) Pharmacology and potential use of cyproterone acetate (a short review). Horm Metab Res 9:1–13
Neumann F, Elger W (1966) The effect of a new antiandrogenic steroid, 6-chloro-17-hydroxy-la, 2a-methylenepregna-4,6-diene-3,20-dione acetate (cyproterone acetate) on the sebaceous glands of mice. J Invest Dermatol 46:561–572
Neumann F, Hamada H (1964) Intrauterine Feminisierung männlicher Rattenfeten durch das stark gestagen wirksame 6-Chlor-∆6-l,2-methylen-17a-hydroxy-progesteronacetat. In: 10. Symp Dtsch Gesellschaft für Endokrinologie, Wien 1963. Springer, Berlin Heidelberg New York, pp 301–304
Neumann F, Schenk B (1976) New antiandrogens and their mode of action. J Reprod Fertil [Suppl] 24:129–149
Neumann F, Steinbeck H (1974) Antiandrogens. In: Eichler O, Farah A, Herken AD, Welch H (eds) Androgens II and antiandrogens. Springer, Berlin Heidelberg New York, pp 485–542 (Handbook of experimental pharmacology, vol 35/2)
Neumann F, Wiechert R (1974) Bedeutung und Problematik der Steroidchemie und -biologie Ein Kapitel aus der modernen Biochemie. In: Deutsches Museum—Abhandlung und Berichte, vol 42, pt 1. Oldenbourg/VDI, Munich/Düsseldorf, pp 1–48
Neumann F, Elger W, von Berswordt-Wallrabe R (1966 a) Aufhebung der Testosteronpropionat-induzierten Unterdrückung des Vaginalzyklus und der Ovulation durch ein antiandrogen wirksames Steroid an Ratten. Acta Endocrinol (Copenh) 52:54–62
Neumann F, Elger W, von Berswordt-Wallrabe R, Kramer M (1966 b) Beeinflussung der Regelmechanismen des Hypophysenzwischenhirnsystems von Ratten durch einen Testosteron-Antagonisten, Cyproteron (l,2a-Methyl-6-chlor-4,6-pregnadien-17a-ol-3,20-dion). Naunyn-Schmiedebergs Arch Exp Pathol Pharmakol 255:221–235
Neumann F, von Berswordt-Wallrabe R, Elger W, Steinbeck H (1967) Hormonhemmer — Untersuchungen mit Testosteron-Antagonisten. In: 18. Mosbacher Colloquium der Gesellschaft für physiologische Chemie: Wirkungsmechanismus der Hormone, Mosbach 1967. Springer, Berlin Heidelberg New York, pp 218–248
Neumann F, Elger W, Steinbeck H, von Berswordt-Wallrabe R (1968) Antiandrogene. 13. Symp Dtsch Gesellschaft für Endokrinologie, Würzburg 1967. In: Klein E (ed) Das Testosteron — Die Struma. Springer, Berlin Heidelberg New York, pp 78–101
Neumann F, Elger W, Steinbeck H (1970 a) Antiandrogens and reproductive development. Philos Trans R Soc Lond [Biol] 259:179–184
Neumann F, Steinbeck H, Elger W (1970 b) Sexualdifferenzierung. In: Symp Dtsch Ges Endokrinol, vol 16. Springer, Berlin Heidelberg New York, pp 58–82
Neumann F, von Berswordt-Wallrabe R, Elger W, Steinbeck H, Hahn JD, Kramer M (1970 c) Aspects of androgen-dependent events as studied by antiandrogens. Recent Prog Horm Res 26:337–410
Neumann F, Richter K-D, Senge T (1975) Animal models in the study of antiprostatic drugs. Vitam Horm 33:103–135
Neumann F, Gräf K-J, Hasan SH, Schenck B, Steinbeck, H (1976 a) Action of antiandrogens on testes function and the male genital tract. In: Hubinont PO (ed) Sperm action. Fifth International Seminar on Reproductive Physiology and Sexual Endocrinology, Brussels, May 1975. Prog Reprod Biol 1:268–283
Neumann F, Gräf K-J, Hasan SH, Schenck B, Steinbeck H (1976 b) Central actions of antiandrogens. International Meeting on Androgens and Antiandrogens, April, Milan
Neumann F, Schacher A, El Etreby MF (1984) Einfluß von Flutamid und Cyproteronacetat auf die Achse Hypothalamus-Hypophyse-Hoden bei männlichen Ratten. In: Helpap B, Senge T, Vahlensieck W (eds) Prostatakarzinom. Pharm and Medical Inform, Frankfurt
Nikkari T (1965) Composition and secretion of the skin surface lipids of the rat; effects of dietary lipids and hormones. Scand J Clin Lab Invest 17:1–140
Nikkari T, Valavaara M (1969) The production of sebum in young rats: effects of age, sex, hypophysectomy and treatment with somatotrophic hormone and sex hormones. J Endocrinol 43:113–118
Noteboom WD, Gorski J (1965) Stereospecific binding of estrogens in the rat uterus. Arch Biochem Biophys 111:559–568
Ober KP, Hennessy JF (1978) Spironolactone therapy for hirsutism in a hyperandrogenic women. Ann Intern Med 89:643–645
Ott F (1968) Hypersexualität, Antiandrogene und Hodenfunktion. Praxis 57:218–220
Ott F, Hoffet H (1968) Beeinflussung von Libido, Potenz und Hodenfunktion durch Antiandrogene. Schweiz Med Wochenschr 98:1812–1815
Pätzold C, Ekerdt R, Töpert M (1986) Parentaneous absorption and accumulation in the pilo-sebaceous unit of topically applied antiandrogenes. J Invest Dermatol 86:328
Pariante F (1971) Preparazione professionale del personale di assistenza psichiatrica. Neopsichiatria 37:112–120
Parvizi N, Elsaesser F, Smidt D, Ellendorf F (1975) Feedback control of LH-secretion in the castrated adult male miniature pig. Acta Endocrinol [Suppl] (Copenh) 193:76 (abst)
Pearlman WH, Pearlman MRJ (1961) The metabolism in vivo ∆4-androstene-3,17-dione-7-3H; its localization in the ventral prostate and other tissues of the rat. J Biol Chem 236:1321–1327
Peets EA, Henson MF, Neri R (1974) On the mechanism of the antiandrogenic action of flutamide (a,a,a,trifluoro-2-methyl-4’-nitro-m-propionotoluidide) in the rat. Endocrinology 94:532–540
Petersen MJ, Zone JJ, Krueger GG (1984) Androgenic response of human sebaceous glands grafted on to the nude mouse. Clin Res 32:18A
Petri H (1969) Exhibitionismus: Theoretische und soziale Aspekte und die Behandlung mit Antiandrogenen. Nervenarzt 40:220–228
Petri H (1972) Möglichkeiten der Verbesserung der sozialen Situation von Sexualdelinquenten durch kombinierte Behandlung — Antiandrogen und Psychotherapie. In: Raspé G (ed) Schering Symposium über Sexualdeviationen und ihre medikamentöse Behandlung, Berlin 1971. Pergamon, Oxford, pp 167–178 (Life science monographs, vol 2
Plewig G, Luderschmidt C (1977) Hamster ear model for sebaceous glands. J Invest Dermatol 68:171–176
Pochi PE, Strauss JS, Mescon H (1962) Sebum secretion and urinary fractional 17-ketosteroid and total 17-hydroxycorticoid excretion in male castrates. J Invest Dermatol 39:475–483
Rager K, Huenges R, Gupta D, Bierich J (1973 a) Einfluß von Cyproteronacetat auf die körperliche Entwicklung und die Steroidausscheidung bei Pubertas praecox. Klin Wochenschr 51:774–775
Rager K, Huenges R, Gupta D, Bierich J (1973 b) The treatment of precocious puberty with cyproterone acetate. Acta Endocrinol (Copenh) 74:399–408
Raspé G (ed) (1972) Schering Symposium über Sexualdeviationen und ihre medikamentöse Behandlung, Berlin 1971. Pergamon, Oxford (Life sciences monographs, vol 2)
Raynaud JP, Ojasoo T, Bouton MM, Philibert D (1979) Receptor binding as a tool in the development of new bioactive steroids. In: Ariens E J (ed) Drug design, vol 8. Academic, New York, pp 169–181
Raynaud JP, Bouton MM, Moguilewsky M, Ojasso T, Philibert D, Beck G, Labrie F, Mornon JP (1980) Steroid hormone receptors and pharmacology. J Steroid Biochem 12:143–157
Raynaud JP, Bonne C, Moguilewsky M, Lefebvre FA, Bélanger A, Labrie F (1984) The pure antiandrogen RU 23908 (Anandron), a candidate of choice for the combined antihormonal treatment of prostatic cancer: a review. Prostate 5:299–311
Reed ND, Manning DD (1973) Long-term maintenance of normal human skin on congenitally athymic (nude) mice. Proc Soc Exp Biol Med 143:350–356
Riemer HM (1969) Eine neuartige Behandlungsmöglichkeit bei Sexualdelinquenten und ihre juristischen Konsequenzen. Schweiz Juristen Ztg 5:69–75
Ritzel G (1971) Zur Antiandrogentherapie mit Cyproteronacetat in der Kinder- und Jugendpsychiatrie. Eine Übersicht über bisherige Erfahrungen. Prax Kinderpsychol 20:165–169
Rony HR, Zakon SJ (1943) Effect of androgen on the sebaceous glands of human skin. Arch Dermatol Syphilol 48:601–604
Rothschild B (1970) Psychiatrisch-klinische Erfahrungen mit einem Antiandrogenpräparat. Schweiz Med Wochenschr 100:1918–1924
Rygaard J (1974) Skin grafts in nude mice. 3. Fate of grafts from man and donors of other taxonomic classes. Acta Pathol Microbiol Scand 82:105–112
Saba P, Pariante F, Marescotti V, Biasci G, Della Valle M, Nicotera M (1971) Effetti indotti dal trattamento con ciproterone acetato in pazienti cerebropatici gravi con manifestazioni di sessualità esaltatà. Neopsichiatria 37:171–177
Sakiz E, Azadian-Boulanger G, Bonne C, Perronnet J, Raynaud JP (1976) Present trends in antiandrogen research. Internat symp on Androgens and Antiandrogens, Milan
Samuels HH, Tomkins GM (1970) Relation of steroid structure to enzyme induction in hepatoma tissue culture cells. J Mol Biol 52:57–74
Sansone G, Reisner RM (1971) Differential rates of conversion of testosterone to dihydrotestosterone in acne and in normal human skin — possible pathogenic factor in acne. J Invest Dermatol 56:366–372
Saunders HL, Kerwin JF (1967) The anti-androgenic activity of B-norandrostanes. In: Martini L, Fraschini F, Motta M (eds) Proceedings of the Und International Congress on Hormonal Steroids, Milan 1966. Excerpta Medica, Amsterdam, pp 599–607
Saunders HL, Holden K, Kerwin JF (1964) The anti-androgenic activity of 17a-methyl-B-nor-testosterone. Steroids 3:687–698
Saunders HL, Tomaszewski J, Pauls J, Zuccarello W (1969) Antifertility effect of 17a-methyl-B-nortestosterone (SKF 7690). Endocrinology 85:960–963
Schacher A, El Etreby MF, Neumann F (1984) Einfluß von Cyproteronacetat, Flutamid und Spironolacton auf die Achse Hypothalamus-Hypophyse-Hoden bei Ratten. Akt Urol 15:218–225
Schenck B, Neumann F (1973) Einfluß von Sexualhormonen auf Knochenreifung und Knochenwachstum weiblicher Ratten. Arzneimittelforschung 23:887–907
Schleusener A, Albring M, Neumann F (1983) Pharmacology of old and new antiandrogens. In: Jeffcoate SL (ed) Androgens and antiandrogens. Wiley, Chichester, pp 71–93
Schmidt JB, Spona J (1980) Östrogen- und Androgenrezeptoren bei Patienten mit Acne vulgaris. Arch Dermatol Res 268:207–215
Schmidt JB, Spona J (1984) 17a-Propylmesterolone a topical antiandrogen in acne patients. XII. Jahrestagung der Arbeitsgemeinschaft Dermatologische Forschung, Lübeck
Schreiber V, Přibyl T, Rohäcova J (1971) Vergleich der Wirkung der Antiandrogene Cyproteronacetat auf das endokrine System der Ratten. Endokrinologie 58:414–424
Schweikert HU, Wilson JD (1974) Regulation of human hair growth by steroid hormones. I. Testosterone metabolism in isolated hairs. J Clin Endocrinol Metab 38:811–819
Scott WW (1971) Cyproterone acetate treatment of disseminated prostatic cancer and benign nodular hyperplasia. In: Raspé G, Brosig W (eds) International symposium on the treatment of carcinoma of the prostate, Berlin, November 1969. Pergamon, Oxford, pp 161–163; 173–180 (Life sciences monographs, vol 2)
Secchi J, Lecaque D, Bouton MM (1984) Morphometric evaluation of local anti-androgenic activity on the rat sebaceous gland. Br J Dermatol 111 [Suppl 27]: 178–179
Seebandt G (1968) Gedanken und Überlegungen zur Behandlung sexualtriebabartiger Psychopathen mit Antiandrogenen. Öff Gesundheitswes 30:66–71
Shuster S (1972) Primary cutaneous virilism. Br Med J 1:285
Shuster S, Thody AJ (1974) The control and measurement of sebum secretion. J Invest Dermatol 62:172–190
Shuster S, Burton JL, Thody AJ, Plummer N, Goolamali SK, Bates D (1973) Melanocyte stimulating hormone and parkinsonism. Lancet 1:463–465
Smith RB, Walsh PC, Goodwin WE (1973) Cyproterone acetate in the treatment of advanced carcinoma of the prostate. J Urol 110:106–108
Steinbeck H, Neumann F (1971 a) Influence of the antiandrogen cyproterone and its acetate on testicular function, onset of puberty, and bone growth and maturation. Proceedings of the Third International Congress on Hormonal Steroids, Hamburg 1970, pp 1007–1015 (Excerpta Medica Found Int Congr ser 219)
Steinbeck H, Neumann F (1971b) Effect of cyproterone acetate on puberty. J Reprod Fertil 26:59–63
Steinbeck H, Mehring M, Neumann F (1971) Comparison of the effects of cyproterone, cyproterone acetate and estradiol on testicular function, accessory sexual glands and fertility in a long-term study on rats. J Reprod Fertil 26:65–76
Strauss JS, Pochi PE (1961) The quantitative gravimetric determination of sebum production. J Invest Dermatol 36:293–298
Strauss JS, Pochi PE (1963) The hormonal control of sebaceous glands. In: Montagna W, Ellis RA, Silver AF (eds) Sebaceous glands. Pergamon, Oxford, pp 220–254 (Advances in biology of skin, vol 4)
Strauss JS, Kligman AM, Pochi PE (1962) The effect of androgens and estrogens on human sebaceous glands. J Invest Dermatol 39:139–155
Stumpf WE (1969) Nuclear concentration of 3H-estradiol in target tissues. Dry-mount autoradiography of vagina, oviduct, ovary, testis, mammary tumor, liver and adrenal. Endocrinology 85:31–37
Takayasu S (1979) Metabolism and action of androgens in skin. Int J Dermatol 18:681–692
Talwar GP, Segal SJ, Evans A, Davidson OW (1964) The binding of estradiol in the uterus: a mechanism for depression of RNA synthesis. Proc Natl Acad Sci USA 52:1059–1066
Talwar GP, Sopori ML, Biswas DK, Segal SJ (1968) Nature and characteristics of the binding of oestradiol-17ß to a uterine macromolecular fraction. Biochem J 107:765–774
Tammi R (1982) Effects of sex steroids on human skin in organ culture. Acta Derm Venereol (Stockh) 62:107–112
Tessmann R (1972) Gedanken zur Behandlung von sexuellen Triebanomalien in der ärztlichen Praxis. Med Welt 23:188–191
Tezön JG, Vazquez MH, Blaquier JA (1982) Androgen-controlled subcellular distribution of its receptor in the rat epididymis: 5 a-dihydrotestoster one-induced translocation is blocked by antiandrogens. Endocrinology 111:2039–2045
Töpert M, Zabel I, Ziegler M (1974) Thin layer gel filtration as a method for routine steroid receptor binding studies. Anal Biochem 62:514–522
Tveter KJ, Aakvaag A (1969) Uptake and metabolism in vivo of testosterone-1,2-3H by accessory sex organs of male rats; influence of some hormonal compounds. Endocrinology 85:683–689
Tveter KJ, Attramadal A (1968) Selective uptake of radioactivity in rat ventral prostate following administration of testosterone-l,2-3H. Methodological considerations. Acta Endocrinol (Copenh) 59:218–226
Vahlensieck W (1970) Miktionsstörungen bei Prostataerkrankungen. Fortschr Med 88:1183–1187
van der Meeren HLM, Thijssen JHH (1984) Circulating androgens in male acne. Br J Dermatol 110:609–611
van Wayjen RGA, van den Ende A (1971/1972) Clinical-pharmacological investigation of cyproterone acetate. Gynecol Invest 2:1–6; 282–289
Vermeulen A (1976) Transport and distribution of androgens at different ages. In: Int symp on androgens and antiandrogens, Milan
Vermorken AJM, Goos CMAA, Wirtz P (1982) Evaluation of the hamster flank organ test for the screening of anti-androgens. Br J Dermatol 106:99–101
Viguier-Martinez M, Pelletier J (1972) Etude comparée des effets de la cyprotérone et de l’acétate de cyprotérone sur la LH hypophysaire, la LH plasmatique et l’appareil génital du rat mâle prépubière (CRH acad Sci ser D 274), pp 2696–2699
Voigt KD, Apostolakis M, Klosterhalfen H (1968) The influence of cyproterone treatment on the excretion of steroids in male patients. In: Tamm J (ed) Testosterone. Proceedings of the Workshop Conference, Tremsbüttel 1967. Thieme, Stuttgart, pp 152–155
von Berswordt-Wallrabe R, Neumann F (1967) Influence of a testosterone antagonist (cyproterone) on pituitary and serum FSH-content in juvenile male rats. Neuroendocrinology 2:107–112
von Berswordt-Wallrabe R, Neumann F (1968 a) Cyproterone and gonadotrophic hormones in rats. Proceedings of the Third International Congress of Endocrinology, Mexico City, 1968. (Excerpta Medica Found Int Congr ser 157, 470) (abstr)
von Berswordt-Wallrabe R, Neumann F (1968 b) Influence of a testosterone antagonist (cyproterone) on pituitary and serum ICSH content in juvenile male rats. Neuroendocrinology 3:332–336
von Schumann H-J (1971) Die Resozialisierung von sexuell abnormen Patienten. Med Monatsschr 25:102–106
Wakeling AE, Furr BJA, Glen AT, Hughes LR (1981) Receptor binding and biological activity of steroidal and nonsteroidal antiandrogens. J Steroid Biochem 15:355–359
Walsh PC, Swerdloff RS, Odell WD (1971) Cyproterone: effect on serum gonadotropins. Biol Reprod 5:97 (abstr)
Walsh PC, Swerdloff RS, Odell WD (1972) Cyproterone: effect on serum gonadotropins in the male. Endocrinology 90:1655–1659
Wein AJ, Murphy JJ (1973) Experience in the treatment of prostatic carcinoma with cyproterone acetate. J Uro 109:68–70
Weissmann A, Bowden J, Frank BL, Horwitz SN, Frost P (1985) Antiandrogenic effects of topically applied spironolactone on the hamster flank organ. Arch Dermatol 121:57–62
Westley B, Rochefort H (1980) A secreted glycoprotein induced by estrogen in human breast cancer cell lines. Cell 20:352–362
Whalen RE, Edwards DA (1969) Effects of the anti-androgen cyproterone acetate on mating behavior and seminal vesicle tissue in male rats. Endocrinology 84:155–156
Whalen RE, Luttge WG (1969) Contraceptive properties of the antiandrogen cyproterone acetate. Nature 223:633
Wheatley VR, Hodgins LT, Coon WM, Kumarasiri M, Berenzweig H, Feinstein JM (1971) Cutaneous lipogenesis: precursors utilised by guinea-pig skin for lipid synthesis. J Lipid Res 12:347
Wiechert R, Steinbeck H, Elger W, Neumann F (1967) Wirkungen und Struktur neuer antiandrogener Steroide. Arzneimittelforschung 17:1103–1116
Wiedeking C (1972) Symposium: Sexualdeviationen und ihre medikamentöse Behandlung, Berlin 1971. Nervenarzt 43:217–218
Winkler K (1968) Die Antiandrogene in der Dermatologie (Gravimetrische Fettbestimmungen während Cyproteronacetatanwendung). Arch Klin Exp Dermatol 233:296–302
Zucker I (1966) Effect of an anti-androgen on the mating behavior of male guinea-pigs and rats. J Endocrinol 35:209–210
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Neumann, F., Töpert, M. (1990). Antiandrogens and Hair Growth: Basic Concepts and Experimental Research. In: Orfanos, C.E., Happle, R. (eds) Hair and Hair Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74612-3_34
Download citation
DOI: https://doi.org/10.1007/978-3-642-74612-3_34
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-74614-7
Online ISBN: 978-3-642-74612-3
eBook Packages: Springer Book Archive